Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

(CLASS 6512)I-HUMAN CASE WEEK 7 56 Y/O FEMALE HEIGHT: 5’5” (165 CM)WEIGHT: 188.0 LB (85.5, Exams of Health sciences

(CLASS 6512)I-HUMAN CASE WEEK 7 56 Y/O FEMALE HEIGHT: 5’5” (165 CM)WEIGHT: 188.0 LB (85.5 KG)REASON FOR ENCOUNTER: BLOOD PRESSURE RECHECK LOCATION: OUTPATIENT CLINIC WITH LABORATORY CAPABILITIES LATEST 2025

Typology: Exams

2024/2025

Available from 07/09/2025

Achieverr
Achieverr 🇺🇸

4.3

(7)

9.6K documents

1 / 34

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
1
(CLASS 6512)I-HUMAN CASE WEEK
7
56
Y/O
FEMALE
HEIGHT: 5’5” (165 CM)WEIGHT: 188.0 LB (85.5 KG)REASON FOR
ENCOUNTER: BLOOD PRESSURE RECHECK LOCATION:
OUTPATIENT CLINIC WITH LABORATORY CAPABILITIES LATEST
2025!
Patient Profile:
Age: 56 years old
Gender: Female
Height: 5’5” (165 cm)
Weight: 188.0 lbs (85.5 kg)
Reason for Visit: Blood pressure recheck
Location: Outpatient clinic with laboratory capabilities
Mode: Learning Mode (feedback appears after each section)
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22

Partial preview of the text

Download (CLASS 6512)I-HUMAN CASE WEEK 7 56 Y/O FEMALE HEIGHT: 5’5” (165 CM)WEIGHT: 188.0 LB (85.5 and more Exams Health sciences in PDF only on Docsity!

1

(CLASS 6512)I-HUMAN CASE WEEK 7 56 Y/O FEMALE

HEIGHT: 5’5” (165 CM)WEIGHT: 188.0 LB (85.5 KG)REASON FOR

ENCOUNTER: BLOOD PRESSURE RECHECK LOCATION:

OUTPATIENT CLINIC WITH LABORATORY CAPABILITIES LATEST

Patient Profile:  Age: 56 years old  Gender: Female  Height: 5’5” (165 cm)  Weight: 188.0 lbs (85.5 kg)  Reason for Visit: Blood pressure recheck  Location: Outpatient clinic with laboratory capabilities  Mode: Learning Mode (feedback appears after each section)

2  Attempts Available: 1 i- Human Case Week 7 Preview Patient Info (Top Left Panel):  Photo: Female patient (appears middle-aged)  Age: 56 y/o  Height: 5'5" (165 cm)  Weight: 188.0 lb (85.5 kg)  Reason for Encounter: Blood pressure recheck  Location: Outpatient clinic with laboratory capabilities Right Panel: Case Instructions  Title: H&P+Dx Case Play Setup and Instructions  Mode: Learning Mode o Feedback is provided after submitting each section.  Attempts Allowed: o 1 attempt permitted for this assignment Sample History for i-Human Case 7: Blood Pressure Recheck HPI (History of Present Illness):  56-year-old female presenting for a follow-up to recheck her blood pressure.  Denies chest pain, palpitations, dizziness, or syncope.  May report occasional headaches or fatigue (check her answers during the interview).  Could mention non-adherence to medications, lifestyle changes, or diet. PMH (Past Medical History):  Hypertension (diagnosed previously)

3  Check if she’s currently on antihypertensives (like lisinopril, amlodipine, etc.)  Over-the-counter meds or supplements? Allergies:  Any known drug or food allergies? FH (Family History):  Any family history of hypertension, diabetes, stroke, or heart disease?  Parents/siblings with cardiovascular risk? SH (Social History):  Smokes? (packs/day and duration)  Alcohol use?  Diet (high sodium or processed food intake?)  Physical activity level  Occupation and stress levels ROS (Review of Systems):  General: Fatigue, weight gain/loss  Cardiovascular: Chest pain, palpitations, edema  Respiratory: SOB, wheezing  Neuro: Headaches, dizziness  GU/GI: Changes in urination or digestion Physical Exam + i-Human Case Week 7 General Appearance:

 Alert and oriented ×  Appears stated age  No acute distress

Vital Signs: (very important for BP follow-up)

 No lesions or ulcers  Warm and dry

5 Assessment + i-Human Case Week 7 Primary Diagnosis: Essential Hypertension (ICD-10: I10)  Rationale: o Patient is here for a BP recheck. o Previous or current elevated BP readings likely present ( ≥130/80 mmHg). o Risk factors: Age >55, BMI ~31.3 (obese), possible sedentary lifestyle or diet issues. o No secondary causes currently evident on exam or history. Possible Secondary/Supporting Diagnoses:

  1. Obesity (ICD-10: E66.9) o BMI ~31.3 based on height/weight. o Major contributor to elevated BP and cardiovascular risk.

2. Hyperlipidemia (ICD-10: E78.5) (if supported by labs)

o Common comorbidity with HTN and obesity.

  1. Prediabetes/Type 2 Diabetes Mellitus (ICD-10: R73.03 or E11.9)

(if glucose/A1C supports it)

4. Nonadherence to Antihypertensive Therapy (ICD-10: Z91.14) (if

she admits missing meds)

□Tips:  Always rank diagnoses in order of importance.  Be sure your top diagnosis is fully supported by HPI, PE, and labs.  In a BP recheck visit, especially in i-Human, they may want you to rule out secondary causes of HTN if anything seems off (e.g., renal bruit, abnormal thyroid, etc.). Test Results + i-Human Case Week 7

  1. Blood Pressure Measurement:
  1. Urinalysis:

7  Proteinuria or hematuria could indicate renal disease secondary to long-standing HTN.  Microalbuminuria can also suggest kidney involvement.

  1. Echocardiogram (if needed):  Could reveal left ventricular hypertrophy (LVH) or diastolic dysfunction if HTN has led to heart changes.
  2. Electrocardiogram (ECG):  Check for LVH, arrhythmias (e.g., atrial fibrillation), or signs of ischemia. □Sample Results Based on the Case (Possible i-Human Output):  BP: 148/92 mmHg (stage 2 hypertension)  Glucose: 102 mg/dL (elevated, possible prediabetes)  LDL: 160 mg/dL (elevated, indicating hyperlipidemia)  Creatinine: 1.1 mg/dL (normal but needs monitoring with ongoing HTN)  Urinalysis: Negative for protein or blood Diagnosis Primary Diagnosis: Essential (Primary) Hypertension  ICD-10: I  Rationale: o Elevated BP on repeat measurement (e.g., ≥140/90 mmHg) o No signs of secondary hypertension (normal TSH, no renal bruits, etc.) o Risk factors: age >55, obesity (BMI ~31), possibly poor diet or sedentary lifestyle

8 Secondary Diagnoses / Comorbidities:

  1. Obesity o ICD-10: E66. o BMI ~31.3 based on height/weight o Contributes to hypertension and cardiovascular risk

2. Hyperlipidemia (if labs show elevated LDL or triglycerides)

o ICD-10: E78. o Increases cardiovascular risk; management should be addressed alongside HTN

3. Prediabetes (if fasting glucose 100+125 mg/dL or A1C 5.7+6.4%)

o ICD-10: R73. o Further elevates cardiovascular risk; consider lifestyle and follow-up A1C testing

  1. Possible Nonadherence to Medication or Lifestyle Recommendations o ICD-10: Z91. o Important to assess for barriers (cost, side effects, understanding) Plan
  2. Hypertension Management (Primary Diagnosis - I10):  Lifestyle Modifications: o DASH diet (low sodium, high fruits/veggies, lean protein) o Sodium restriction: <2,300 mg/day, ideally <1,500 mg/day o Weight loss: Target 5+10% body weight reduction o Exercise: ≥ 150 min/week moderate-intensity aerobic activity o Limit alcohol: ≤1 drink/day (women) o Smoking cessation (if applicable)  Pharmacologic Therapy: o Start antihypertensive therapy (if not already prescribed)  First-line: Thiazide diuretic, ACE inhibitor, ARB, or CCB  Example: Lisinopril 10 mg daily (adjust per labs/BP)

o Monitor for side effects (e.g., ACEi: cough, hyperkalemia, renal function)  Monitor BP at home: Keep a log and bring it to follow-up

 EKG if any cardiac symptoms or baseline evaluation warranted  Annual eye exam for retinal changes (HTN-related)

10

  1. Follow-Up:  Return in 2+4 weeks to reassess BP and med tolerance  Reinforce medication adherence and lifestyle changes  Adjust meds based on home BP log and labs Management Plan
  2. Lifestyle Modifications:  DASH diet: Emphasize fruits, vegetables, whole grains, and low sodium (<1,500+2,300 mg/day).  Weight loss: Encourage gradual loss (goal: 5+10% of body weight).  Exercise: ≥150 minutes of moderate-intensity aerobic activity per week.  Limit alcohol: No more than 1 drink/day.  Smoking cessation: Offer counseling/support if applicable.
  3. Pharmacologic Treatment:  Initiate antihypertensive therapy: o Start Lisinopril 10 mg PO daily (or another first-line agent such as a thiazide or CCB, depending on contraindications/labs). o Monitor renal function and electrolytes 1+2 weeks after initiation.  Consider statin therapy (e.g., Atorvastatin 20 mg PO daily) based on ASCVD risk factors (age, BP, lipids).
  4. Patient Education:  Educate on: o Importance of medication adherence. o Monitoring BP at home with log. o Potential side effects of meds (e.g., ACE inhibitors).  Discuss signs/symptoms that require prompt evaluation (e.g., chest pain, dizziness, swelling).

11  BMP (check potassium and creatinine) in 1+2 weeks after starting ACE inhibitor.  Lipid panel to confirm hyperlipidemia and assess need for statin therapy.  HbA1c or fasting glucose if not already obtained * screen for prediabetes/diabetes.  Optional: EKG if cardiac symptoms or to check for left ventricular hypertrophy.

  1. Follow-Up:  Recheck BP in 2+4 weeks to assess response to treatment.  Review home BP readings and medication tolerance.  Adjust meds or add additional antihypertensives if BP goal not met.  Routine follow-up every 3+6 months once stable. SOAP Note + Week 7 i-Human Case S + Subjective Chief Complaint: “I’m here to have my blood pressure rechecked.” HPI: 56-year-old female presents for a follow-up visit to evaluate previously elevated blood pressure. She reports feeling generally well, with no chest pain, shortness of breath, dizziness, or palpitations. She denies visual changes, headaches, or swelling. She has not been consistently monitoring her blood pressure at home and may not be consistently taking prescribed medication (if applicable). No recent illness or significant lifestyle changes. PMH:  Hypertension (diagnosed previously)  Possible obesity

 Hyperlipidemia or prediabetes (suspected)  No history of cardiovascular events